Dr. Mark Donald Fleming, MD

Dr. Fleming practices at Avera Heart Hospital in Sioux Falls, South Dakota, part of Avera Health.

Dr. Fleming's NPI, 1841255932, was assigned on April 20, 2006. Dr. Fleming graduated from College of Medicine - Tucson in 2003. Dr. Fleming holds South Dakota license 14037.

Dr. Fleming's primary practice is Avera Heart Hospital, at 4500 W 69th St, Sioux Falls, SD 57108 in Lincoln County. The practice phone is (605) 977-7000.

Dr. Fleming's primary practice is Avera Heart Hospital in Sioux Falls, South Dakota, part of Avera Health. Dr. Fleming is also affiliated with Avera McKennan Hospital & University Health Center. The medical group on file is Avera Heart Hospital of South Dakota. Dmand AI also links Dr. Fleming to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleming practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Fleming's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Fleming is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Fleming's licenses on file in 7 states: South Dakota, Oregon, Iowa, Kentucky, Minnesota, Wisconsin and Arizona.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Fleming treats.

CMS data shows 2,121 Medicare services from Dr. Fleming across 33 procedure codes in 2024, for 891 Medicare patients. Medicare paid $140,123 for them.

CMS counts 891 Medicare patients who saw Dr. Fleming in 2024. The largest group is 65 to 74, with 397 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fleming's median patient age at 69, with 48% women.

In 2024, Dr. Fleming wrote 363 Medicare Part D claims for 108 patients. 77% of them were for generic drugs. CMS names the drug for 311 of them, across 5 drugs with 11 or more claims each, at $55,768 in total drug cost. In 2023, CMS named 129 claims across 3 drugs.

Dr. Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 86 procedures of leg revascularization (restoring blood flow) by Dr. Fleming, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 34 papers to Dr. Fleming, published from 2012 to 2022. 2015 was the busiest year, with 8. The most frequent topics are Endovascular Procedures, Blood Vessel Prosthesis Implantation and Vascular Patency. Dr. Fleming has published most often in J Vasc Surg. Dr. Fleming's most frequent co-authors are Gustavo S. Oderich, MD, Audra A. Duncan, MD and Thomas C. Bower, MD.

Dmand AI links Dr. Fleming to 1 clinical trial. Conditions studied include Atherosclerosis and Arteriosclerosis.

CMS Open Payments shows 337 general payments to Dr. Fleming from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 31% of the total. Boston Scientific Corporation paid the most, $40,380.

Dmand AI lists 5 awards for Dr. Fleming, most recently Outstanding Senior Student in Surgery Award in 2003.

Dr. Fleming graduated from College of Medicine - Tucson in 2003. Dr. Fleming is a member of ACS and SVS.